Safety and Effectiveness Evaluation of Two Kinds of Peritoneal Dialysate (SEED)
The Prospective, Randomized, Parallel, Controlled, Multi-center Clinical Study of Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate
Sponsor: Chinese PLA General Hospital
Listed as NCT01779557, this PHASE4 trial focuses on Kidney Failure,Chronic and remains completed. Sponsored by Chinese PLA General Hospital, it has been updated 13 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Apr 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Sep 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE4
-
Feb 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE4
▶ Show 8 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE4
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
-
Feb 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE4
-
Aug 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Jul 2019 [monthly]
Recruiting PHASE4
-
Jul 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Status: Active Not Recruiting → Recruiting
-
Jan 2017 — Jul 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
Feb 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese PLA General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .